Drug Information

Drug General Information
Drug ID
D0T3AT
Former ID
DIB018971
Drug Name
BIC1
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531444]
Structure
Download
2D MOL
Formula
C17H16N4S2
InChI
InChI=1S/C17H16N4S2/c1-20-14-8-4-5-9-15(14)21(17(20)22)10-11-23-16-18-12-6-2-3-7-13(12)19-16/h2-9H,10-11H2,1H3,(H,18,19)
InChIKey
KDPSGIFCBZTBEZ-UHFFFAOYSA-N
PubChem Compound ID
672548
PubChem Substance ID
873026, 3207214, 3520300, 5656316, 7915616, 9279196, 11503452, 48125999, 51695743, 85824804, 87219513, 88549016, 92292557, 108120858, 109850780, 118019894, 118258236, 121360383, 124551167, 124963338, 136969524, 169620040, 170474592, 172908707, 187051812, 233776468
Target and Pathway
Target(s) Bromodomain-containing protein 2 Target Info Inhibitor [531444]
NetPath Pathway TGF_beta_Receptor Signaling Pathway
Pathway Interaction Database Regulation of retinoblastoma protein
WikiPathways Chemical Compounds to monitor Proteins
References
Ref 531444Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors. Chem Biol. 2011 Apr 22;18(4):495-507.
Ref 531444Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors. Chem Biol. 2011 Apr 22;18(4):495-507.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.